Skip to content

MCS+ 09081-00

by Haemonetics Corporation

MCS+ 09081-00 is an apheresis system (FDA Class II; FDA product code GKT, Separator, automated, blood cell, diagnostic) made by Haemonetics Corporation, listed in FDA GUDID since 17 Apr 2017 (UDI-DI 10812747012485), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10812747012485 UDI-DI Date17 Apr 2017ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
SDP/PLP PROT MANUL,LN 09081-00
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Mcs+
Generic name
Apheresis system
Model / reference
09081-00
Primary DI / UDI-DI
10812747012485
FDA product code
GKT
GMDN term
Apheresis system
Device class
Class II
Regulation number
864.9245
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Apheresis system.

Other devices from Haemonetics Corporation

See all devices from Haemonetics Corporation →

Properties

  • Prescription use
Other properties (14, all answered No)